Skip to main content
profile image
Selected Works of Walter J. Urba, MD, PhD
Article
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B‐cell lymphoma
American Journal of Hematology (2020)
  • John Timmerman, UCLA Medical Center
  • Charles Herbaux, Centre Hospitalier Régional Universitaire de Lille Lille France
  • Vincent Ribrag, Institut Gustave Roussy
  • Andrew D. Zelenetz, Memorial Sloan Kettering Cancer Center
  • Roch Houot, French Institute of Health and Medical Research
  • Sattva S. Neelapu, University of Texas MD Anderson Cancer Center
  • Theodore Logan, Indiana University – Purdue University Indianapolis
  • Izidore S. Lossos, University of Miami
  • Walter Urba, Earle A. Chiles Research Institute Providence Cancer Center Portland Oregon
  • Gilles Salles, University of Lyon
  • Radhakrishnan Ramchandren, Karmanos Cancer Institute Detroit Michigan
  • Caron Jacobson, Harvard University
  • John Godwin, Earle A. Chiles Research Institute Providence Cancer Center Portland Oregon
  • Cecilia Carpio, Autonomous University of Barcelona
  • Deanne Lathers, Bristol-Myers Squibb
  • Yali Liu, Bristol-Myers Squibb
  • Jaclyn Neely, Bristol-Myers Squibb
  • Satyendra Suryawanshi, Bristol-Myers Squibb
  • Yoshinobu Koguchi, Earle A. Chiles Research Institute Providence Cancer Center Portland Oregon
  • Ronald Levy, Stanford University
Link
Disciplines
Publication Date
February 29, 2020
DOI
10.1002/AJH.25757
Citation Information
John Timmerman, Charles Herbaux, Vincent Ribrag, Andrew D. Zelenetz, et al.. "Urelumab alone or in combination with rituximab in patients with relapsed or refractory B‐cell lymphoma" American Journal of Hematology Vol. 95 Iss. 5 (2020) p. 510 - 520
Available at: http://works.bepress.com/walter-urba/282/